The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorization for the mRNA respiratory syncytial...
At its June 2024 meeting, the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) gave Winrevair (sotatercept; Merck Sharp & Dohme)...
A marketing authorization for Zegalogue (dasiglucagon, Zealand Pharma) for the treatment of severe hypoglycemia in patients aged 6 years and older with diabetes has been...
